{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T04:28:57Z","timestamp":1741926537617,"version":"3.38.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,13]]},"DOI":"10.7759\/cureus.80532","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:55:18Z","timestamp":1741913718000},"source":"Crossref","is-referenced-by-count":0,"title":["Recognizing Recurrence: History Over Symptoms in Metastatic Melanoma"],"prefix":"10.7759","author":[{"given":"John","family":"Solomon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niyousha","family":"Naderi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qui Cheun","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5114\/pdia.2013.33376","article-title":"Skin melanocytes: biology and development","volume":"30","author":"Cichorek M","year":"2013","unstructured":"Cichorek M, Wachulska M, Stasiewicz A, Tymi\u0144ska A. Skin melanocytes: biology and development. Postepy Dermatol Alergol. 2013, 30:30-41. 10.5114\/pdia.2013.33376","journal-title":"Postepy Dermatol Alergol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1215\/s115285170300067x","article-title":"Brain metastases in melanoma: roles of neurotrophins","volume":"6","author":"Denkins Y","year":"2004","unstructured":"Denkins Y, Reiland J, Roy M, et al.. Brain metastases in melanoma: roles of neurotrophins. Neuro Oncol. 2004, 6:154-65. 10.1215\/s115285170300067x","journal-title":"Neuro Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.386","article-title":"Melanocytes: a window into the nervous system","volume":"132","author":"Yaar M","year":"2012","unstructured":"Yaar M, Park HY. Melanocytes: a window into the nervous system. J Invest Dermatol. 2012, 132:835-45. 10.1038\/jid.2011.386","journal-title":"J Invest Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.165.6.7484597","article-title":"Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content","volume":"165","author":"Isiklar I","year":"1995","unstructured":"Isiklar I, Leeds NE, Fuller GN, Kumar AJ. Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content. AJR Am J Roentgenol. 1995, 165:1503-12. 10.2214\/ajr.165.6.7484597","journal-title":"AJR Am J Roentgenol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.56.7.548","article-title":"A rare case of intracranial metastatic amelanotic melanoma with cyst","volume":"56","author":"Ogawa R","year":"2003","unstructured":"Ogawa R, Aoki R, Hyakusoku H. A rare case of intracranial metastatic amelanotic melanoma with cyst. J Clin Pathol. 2003, 56:548-51. 10.1136\/jcp.56.7.548","journal-title":"J Clin Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14155","article-title":"High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma","volume":"174","author":"Zaragoza J","year":"2016","unstructured":"Zaragoza J, Caille A, Beneton N, Bens G, Christiann F, Maillard H, Machet L. High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma. Br J Dermatol. 2016, 174:146-51. 10.1111\/bjd.14155","journal-title":"Br J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.04.471","article-title":"Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy(\u2606)","volume":"31","author":"Owen CN","year":"2020","unstructured":"Owen CN, Shoushtari AN, Chauhan D, et al.. Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy(\u2606). Ann Oncol. 2020, 31:1075-82. 10.1016\/j.annonc.2020.04.471","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.0440","article-title":"Risk of melanoma recurrence after diagnosis of a high-risk primary tumor","volume":"155","author":"von Schuckmann LA","year":"2019","unstructured":"von Schuckmann LA, Hughes MC, Ghiasvand R, et al.. Risk of melanoma recurrence after diagnosis of a high-risk primary tumor. JAMA Dermatol. 2019, 155:688-93. 10.1001\/jamadermatol.2019.0440","journal-title":"JAMA Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14981","article-title":"Early time to recurrence predicts worse survival in patients with localized or regionally advanced cutaneous melanoma","volume":"34","author":"Liang C","year":"2021","unstructured":"Liang C, Hu W, Li J, Zhang X, Zhou Z, Liang Y. Early time to recurrence predicts worse survival in patients with localized or regionally advanced cutaneous melanoma. Dermatol Ther. 2021, 34:e14981. 10.1111\/dth.14981","journal-title":"Dermatol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/282120-recognizing-recurrence-history-over-symptoms-in-metastatic-melanoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:55:19Z","timestamp":1741913719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/282120-recognizing-recurrence-history-over-symptoms-in-metastatic-melanoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.80532","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,13]]}}}